NovoCure Aktie

NovoCure für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A140ML / ISIN: JE00BYSS4X48

<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
<
Aktion
Portfolio
Watchlist
>
30.10.2025 13:53:13

Novocure Posts Wider Loss In Q3

(RTTNews) - Novocure (NVCR) reported a third quarter net loss of $37.3 million compared to a loss of $30.6 million, prior year. Net loss per ordinary share was $0.33 compared to a loss of $0.28. Analysts on average expected the company to report a loss per share of $0.42, for the quarter. Analysts' estimates typically exclude special items.

Total net revenues for the quarter were $167.2 million, an increase of 8% compared to the same period in 2024. The company said this increase was primarily driven by active patient growth, as well as $3.3 million in exchange rate benefits.

Shares of Novocure are up 7% in pre-market trade on Thursday.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Nachrichten zu NovoCure Limited

mehr Nachrichten
Keine Nachrichten verfügbar.

Analysen zu NovoCure Limited

mehr Analysen
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

NovoCure Limited 14,61 -0,58% NovoCure Limited